The agreement comes after a successful implementation where GlaxoSmithKline (GSK) experienced the ease of use that empowers operators, engineers and management to positively affect their overall equipment effectiveness (OEE), and consequently, their production costs.
Activplant’s Throughput Analyzer software product is currently implemented within key GSK facilities in North America and the UK.
Julian Ward, application champion of GSK, said: “Once we saw how quickly Activplant’s Throughput Analyzer could be implemented and drive results in our facility in North Carolina, we felt that it made sense to negotiate a global framework agreement to reduce complexity where our facilities wish to consider implementing OEE projects.”